We often work with organizations adding capacity, transferring new products, and adding existing products from other sites into their “preferred” plants. These facilities range from CMOs to traditional name-brand pharmaceutical companies. In each case, the receiving site is focused on schedule and budget. These competing targets have often distracted personnel from understanding and embracing newer technologies, thereby bypassing lower-cost options and faster project implementation. The following discussion covers actual cases of aseptic fill sites in the U.S. and their new projects.
To read more, go to https://www.bioprocessonline.com/doc/not-your-grandma-s-aseptic-filling-line-letting-go-of-tunnels-washers-and-other-aseptic-vestiges-0001
